DETECTION, MEASUREMENT AND IMAGING OF CELLS, SUCH AS CANCER, AND OTHER BIOLOGICAL SUBSTANCES USING TARGETED NANOPARTICLES AND MAGNETIC PROPERTIES THEREOF Russian patent published in 2016 - IPC A61F2/02 

Abstract RU 2587902 C2

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely, to the means of detecting and measuring cells or substances via targeted nanoparticles. Apparatus comprises a magnetizing subsystem for magnetization nanoparticles which are associated with one or more specified types of cancer cells, or biological substances in a patient, a sensor subsystem to detect the residual magnetic field in the region of interest of the patient after the unbound nanoparticles back to the random magnetization, and for a time nanoparticles of transition related to the random homogeneous magnetization, and the management and analysis of the residual magnetic field to detect, measure or determine the location of one or more specific types of cancer cells, or biological substances in a patient. Method uses a device and includes placing a plurality of targeted nanoparticles to the patient, wherein each of the plurality of targeted nanoparticles include paramagnetic nanoparticle conjugated to a targeting agent that binds to one or more specified types of cancer cells, or biological substances, the use of the magnetizing subsystem sensor subsystem and control system and analysis.

EFFECT: use of the invention allows early detection of tissue damage.

21 cl, 27 dwg

Similar patents RU2587902C2

Title Year Author Number
ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF 2011
  • Makerdzhi Pinku
RU2595403C2
COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS 2012
  • Etvol, Siminder
  • Khongo, Dzho-Enn
  • Lekner, Mark
  • Punnus, Elizabet
  • Rubinfeld, Bonni
  • Vidzh, Radzhesh
RU2641968C2
METHOD OF INHIBITING MIGRATION OF CANCER CELLS 2006
  • Kharris Dehvid T.
  • Tsang Tom S.
  • Khe Ksiangui
  • Pipes Brajan L.
  • Meade-Tollin Linda S.
RU2404805C2
IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY 2013
  • Sakhin Ugur
  • Tyurechi Ezlem
  • Kozlovski Mikhael
  • Uzener Dirk
RU2644686C2
CANCER MARKER AND THERAPEUTIC TARGET 2008
  • Behlkvill Frehnsis
  • Slehttenaar Vajolet
  • Uilson Dzhulija
  • Van Jaokheh
  • Sk'Oppa Titsiana
RU2529797C2
DUOCARMICIN ADC SHOWING IMPROVED ANTI-TUMOUR ACTIVITY IN VIVO 2015
  • Dokter Villem
  • Besker Patrik Khenri
  • Gudings Peter Jokhannes
  • Verkhejden Gejsbertus Fransiskus Mariya
RU2689779C2
ANTI-CANCER THERAPY, DIRECTED AGAINST CANCER STEM CELLS AND FORMS OF CANCER, RESISTANT TO TREATMENT BY MEDICATIONS 2010
  • Burger Angelika
RU2568834C2
METHOD OF PREVENTION AND/OR TREATMENT OF CANCEROUS DISEASES 2006
  • Val'Defner Norbert
  • Jordan Andreas
  • Shol'Ts Regina
RU2480201C2
AXL SIGNALLING INHIBITION IN ANTIMETASTATIC THERAPY 2011
  • Dzhacha Amato Dzh.
  • Renkin Ehrin Bruno
  • Kochran Dzhennifer R.
  • Dzhons Duglas
  • Kariolis Mikhalis
  • Fu Katerin
  • Mjao Juj
RU2556822C2
APPLICATION OF ANTIBODIES AGAINST α5β1 FOR INHIBITION OF CANCER CELLS PROLIFERATION 2005
  • Ramakrishnan Vanitkha
  • Bkhaskar Vinaj
  • Kho Sun'
  • Mjurrej Richard
  • Lo Debbi
RU2361614C2

RU 2 587 902 C2

Authors

Flinn Edvard R.

Dates

2016-06-27Published

2010-11-05Filed